CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 9 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66 | -34.7% | 185,500 | +8.7% | 0.00% | – |
| Q2 2023 | $101 | +4.1% | 170,700 | +0.6% | 0.00% | – |
| Q1 2023 | $97 | -13.4% | 169,700 | +0.8% | 0.00% | – |
| Q4 2022 | $112 | -100.0% | 168,400 | +0.5% | 0.00% | – |
| Q3 2022 | $245,000 | +260.3% | 167,600 | +166.0% | 0.00% | – |
| Q2 2022 | $68,000 | -91.5% | 63,000 | -63.3% | 0.00% | -100.0% |
| Q2 2020 | $798,000 | – | 171,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |